This report focuses on the global Pre-Implantation Genetic Diagnosis (PGD) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pre-Implantation Genetic Diagnosis (PGD) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Roche Genea Limited Quest Diagnostics Illumina, Inc. Natera, Inc. Cooper Medical, Inc. LabCorp California Pacific Medical Center (CPMC) Thermo Fisher Scientific Inc. IGENOMIX Reproductive Genetic Innovations CombiMatrix Market segment by Type, the product can be split into Chromosomal Abnormalities X-linked Diseases Freeze Embryo Testing Aneuploidy Screening HLA Others Market segment by Application, split into Stem Cell Therapy IVF Prognosis Late-Onset Genetic Disorders Inherited Genetic Disease Others Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Pre-Implantation Genetic Diagnosis (PGD) status, future forecast, growth opportunity, key market and key players. To present the Pre-Implantation Genetic Diagnosis (PGD) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions. In this study, the years considered to estimate the market size of Pre-Implantation Genetic Diagnosis (PGD) are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
This research study involves broad usage of both secondary and primary data sources. The research process involves the identification of numerous factors which affect the industry, comprising the market environment, government policy, historical data, present trends in the market, competitive landscape, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.
Market Estimation
Top-down and bottom-up approaches are used for validating the market size for companies, regional segments along with relevant market segmentations such as product type and application.
This report includes market estimations which are based on the marketed sale price of a product. Further breakdown of product segments, particular market share are formed based on the weightage assigned to every segment, which is derived of their usage rate and average price. The entire probable factors which effect the markets and influence them in a great way are included in this research report; and have been accounted for, studied in-depth and are confirmed through primary research. These are then studies to get the final qualitative and quantitative data. Any of the factors such as the outcome of inflation, economic downfall, and any kind of policy and regulatory alterations and/or other such factors are not accounted for in the market forecast. All of this data is amalgamated and included with thorough inputs and analysis from Gravitas Market Insights is curated in this report.
Along with the previously mentioned approaches, various data triangulation methods, in order to conduct market estimations and market forecasting for the complete market segments are detailed in this report. Key Companies present in the said market are also acknowledged via in-depth secondary research and primary research.
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Pre-Implantation Genetic Diagnosis (PGD) Revenue 1.4 Covid-19 Implications on Market by Type 1.4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Chromosomal Abnormalities 1.4.3 X-linked Diseases 1.4.4 Freeze Embryo Testing 1.4.5 Aneuploidy Screening 1.4.6 HLA 1.4.7 Others 1.5 Covid-19 Implications on Market by Application 1.5.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application: 2020 VS 2026 1.5.2 Stem Cell Therapy 1.5.3 IVF Prognosis 1.5.4 Late-Onset Genetic Disorders 1.5.5 Inherited Genetic Disease 1.5.6 Others 1.6 Coronavirus Disease 2019 (Covid-19): Pre-Implantation Genetic Diagnosis (PGD) Industry Impact 1.6.1 How the Covid-19 is Affecting the Pre-Implantation Genetic Diagnosis (PGD) Industry 1.6.1.1 Pre-Implantation Genetic Diagnosis (PGD) Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19?s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Pre-Implantation Genetic Diagnosis (PGD) Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Pre-Implantation Genetic Diagnosis (PGD) Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Covid-19 Implications on Global Pre-Implantation Genetic Diagnosis (PGD) Market Perspective (2015-2026) 2.2 Covid-19 Implications on Global Pre-Implantation Genetic Diagnosis (PGD) Growth Trends by Regions 2.2.1 Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Pre-Implantation Genetic Diagnosis (PGD) Historic Market Share by Regions (2015-2020) 2.2.3 Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter?s Five Forces Analysis 2.3.5 Pre-Implantation Genetic Diagnosis (PGD) Market Growth Strategy 2.3.6 Primary Interviews with Key Pre-Implantation Genetic Diagnosis (PGD) Players (Opinion Leaders) 3 Covid-19 Implications on Competition Landscape by Key Players 3.1 Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Market Size 3.1.1 Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Revenue (2015-2020) 3.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2015-2020) 3.1.3 Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio 3.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2019 3.3 Pre-Implantation Genetic Diagnosis (PGD) Key Players Head office and Area Served 3.4 Key Players Pre-Implantation Genetic Diagnosis (PGD) Product Solution and Service 3.5 Date of Enter into Pre-Implantation Genetic Diagnosis (PGD) Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Covid-19 Implications on Market Size by Type (2015-2026) 4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Type (2015-2020) 4.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2021-2026) 5 Covid-19 Implications on Market Size by Application (2015-2026) 5.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) 5.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020) 6.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in North America (2019-2020) 6.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) 6.4 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) 7 Europe 7.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020) 7.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in Europe (2019-2020) 7.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) 7.4 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) 8 China 8.1 China Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020) 8.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in China (2019-2020) 8.3 China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) 8.4 China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) 9 Japan 9.1 Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020) 9.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in Japan (2019-2020) 9.3 Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) 9.4 Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020) 10.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) 10.4 Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) 11 India 11.1 India Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020) 11.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in India (2019-2020) 11.3 India Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) 11.4 India Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2015-2020) 12.2 Pre-Implantation Genetic Diagnosis (PGD) Key Players in Central & South America (2019-2020) 12.3 Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2015-2020) 12.4 Central & South America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Roche 13.1.1 Roche Company Details 13.1.2 Roche Business Overview and Its Total Revenue 13.1.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.1.4 Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020)) 13.1.5 Roche Recent Development 13.2 Genea Limited 13.2.1 Genea Limited Company Details 13.2.2 Genea Limited Business Overview and Its Total Revenue 13.2.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.2.4 Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.2.5 Genea Limited Recent Development 13.3 Quest Diagnostics 13.3.1 Quest Diagnostics Company Details 13.3.2 Quest Diagnostics Business Overview and Its Total Revenue 13.3.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.3.4 Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.3.5 Quest Diagnostics Recent Development 13.4 Illumina, Inc. 13.4.1 Illumina, Inc. Company Details 13.4.2 Illumina, Inc. Business Overview and Its Total Revenue 13.4.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.4.4 Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.4.5 Illumina, Inc. Recent Development 13.5 Natera, Inc. 13.5.1 Natera, Inc. Company Details 13.5.2 Natera, Inc. Business Overview and Its Total Revenue 13.5.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.5.4 Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.5.5 Natera, Inc. Recent Development 13.6 Cooper Medical, Inc. 13.6.1 Cooper Medical, Inc. Company Details 13.6.2 Cooper Medical, Inc. Business Overview and Its Total Revenue 13.6.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.6.4 Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.6.5 Cooper Medical, Inc. Recent Development 13.7 LabCorp 13.7.1 LabCorp Company Details 13.7.2 LabCorp Business Overview and Its Total Revenue 13.7.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.7.4 LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.7.5 LabCorp Recent Development 13.8 California Pacific Medical Center (CPMC) 13.8.1 California Pacific Medical Center (CPMC) Company Details 13.8.2 California Pacific Medical Center (CPMC) Business Overview and Its Total Revenue 13.8.3 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.8.4 California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.8.5 California Pacific Medical Center (CPMC) Recent Development 13.9 Thermo Fisher Scientific Inc. 13.9.1 Thermo Fisher Scientific Inc. Company Details 13.9.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue 13.9.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.9.4 Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.9.5 Thermo Fisher Scientific Inc. Recent Development 13.10 IGENOMIX 13.10.1 IGENOMIX Company Details 13.10.2 IGENOMIX Business Overview and Its Total Revenue 13.10.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Introduction 13.10.4 IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 13.10.5 IGENOMIX Recent Development 13.11 Reproductive Genetic Innovations 10.11.1 Reproductive Genetic Innovations Company Details 10.11.2 Reproductive Genetic Innovations Business Overview and Its Total Revenue 10.11.3 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Introduction 10.11.4 Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 10.11.5 Reproductive Genetic Innovations Recent Development 13.12 CombiMatrix 10.12.1 CombiMatrix Company Details 10.12.2 CombiMatrix Business Overview and Its Total Revenue 10.12.3 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Introduction 10.12.4 CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2015-2020) 10.12.5 CombiMatrix Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details
